Bioventus (BVS) Total Debt (2020 - 2026)

Bioventus (BVS) has reported Total Debt for 7 consecutive years, with $248.5 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Total Debt fell 27.19% year-over-year to $248.5 million; the trailing twelve-month figure through Jun 2026 stood at $248.5 million (down 27.19% YoY), and the FY2025 full-year result was $294.0 million, down 12.42% from the prior year.
• Total Debt declined to $248.5 million in Q2 2026 per BVS's latest filing, from $272.1 million in the prior quarter.
• Across five years, Total Debt topped out at $445.6 million in Q2 2023 and bottomed at $248.5 million in Q2 2026.
• Historically, Total Debt has averaged $362.4 million across 5 years, with a median of $378.6 million in 2022.
• The sharpest annual moves came in 2022 and 2026: Total Debt soared 139.19% in 2022, then fell 27.19% in 2026.
• Over 5 years, Total Debt stood at $418.1 million in 2022, then retreated by 5.55% to $394.8 million in 2023, then fell by 15.0% to $335.6 million in 2024, then decreased by 12.42% to $294.0 million in 2025, then fell by 15.48% to $248.5 million in 2026.
• According to Business Quant data, Total Debt over the past three periods registered $248.5 million, $272.1 million, and $294.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.